Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR4 | Q5NUL3 | 5/20 | 0.40 |
| ▸ | MRGPRX4 | Q96LA9 | 5/20 | 0.37 |
| ▸ | FFAR1 | O14842 | 3/20 | 0.35 |
| ▸ | CETP | P11597 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 2/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.34 |
| ▸ | RXRA | P19793 | 1/20 | 0.33 |
| ▸ | RXRB | P28702 | 1/20 | 0.33 |
| ▸ | RXRG | P48443 | 1/20 | 0.33 |
| ▸ | DHODH | Q02127 | 1/20 | 0.33 |
| ▸ | MAOB | P27338 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17358232 | 0.93 | APP (0.37) | FFAR4CETPMAPTCYP2C9CYP2C19 | |
| SCHEMBL18427307 | 0.81 | PIN1 (0.38) | MAPTL3MBTL1MAOB | |
| SCHEMBL5268318 | 0.81 | PIN1 (0.38) | MAPTL3MBTL1MAOB | |
| SCHEMBL5265501 | 0.81 | PIN1 (0.38) | MAPTL3MBTL1MAOB | |
| SCHEMBL17523255 | 0.80 | MRGPRX4 (0.43) | MRGPRX4FFAR1 | |
| SCHEMBL17358249 | 0.78 | CYP3A4 (0.43) | FFAR4MRGPRX4FFAR1MAPTSMN1; SMN2 | |
| SCHEMBL5523109 | 0.78 | SIRT1 (0.41) | MAPTCYP2C19L3MBTL1MAOB | |
| SCHEMBL5620552 | 0.78 | SIRT1 (0.41) | MAPTCYP2C19L3MBTL1MAOB | |
| SCHEMBL3932082 | 0.71 | STING1 (0.41) | SMN1; SMN2MAOB | |
| SCHEMBL15450266 | 0.71 | CYP3A4 (0.44) | MAPTSMN1; SMN2TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150368223-A1 | NOVEL APPROACH FOR SYNTHESIS OF CATECHINS | EPIRIUM BIO INC. | 2015-12-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150368223-A1 | NOVEL APPROACH FOR SYNTHESIS OF CATECHINS | NQO1, COMT, NNMT | FFAR4 1730/4885MRGPRX4 4774/4885FFAR1 2075/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.